1
|
Jinyi Z, Quanyong X, Ran T, Jie Y, Ping L
and Ming W: Analysis on surveillance of cause death in Jiangsu
province during 2007. Jiangsu J Prev Med 2008. 19:74–75. 2008.
|
2
|
Rice TW, Rusch VW, Apperson-Hansen C, et
al: Worldwide esophageal cancer collaboration. Dis Esophagus.
22:1–8. 2009. View Article : Google Scholar
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: the potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Schetter AJ, Heegaard NHH and Harris CC:
Inflammation and cancer: interweaving microRNA, free radical,
cytokine and p53 pathways. Carcinogenesis. 31:37–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ahmed FE: Role of miRNA in carcinogenesis
and biomarker selection: a methodological view. Expert Rev Mol
Diagn. 7:569–603. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kan T and Meltzer SJ: MicroRNAs in
Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin
Pharmacol. 9:727–732. 2009.
|
11
|
Yang HS, Gu J, Wang KK, et al: MicroRNA
expression signatures in Barrett’s esophagus and esophageal
adenocarcinoma. Clin Cancer Res. 15:5744–5752. 2009.
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(T)(-Delta Delta C) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
14
|
Chen X, Hu ZB, Wang WJ, et al:
Identification of ten serum microRNAs from a genome-wide serum
microRNA expression profile as novel noninvasive biomarkers for
nonsmall cell lung cancer diagnosis. Int J Cancer. 130:1620–1628.
2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hu YX, Correa AM, Hoque A, et al:
Prognostic significance of differentially expressed miRNAs in
esophageal cancer. Int J Cancer. 128:132–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wiggins JF, Ruffino L, Kelnar K, et al:
Development of a lung cancer therapeutic based on the tumor
suppressor microRNA-34. Cancer Res. 70:5923–5930. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Guo Y, Chen Z, Zhang L, et al: Distinctive
microRNA profiles relating to patient survival in esophageal
squamous cell carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ogawa R, Ishiguro H, Kuwabara Y, et al:
Expression profiling of micro-RNAs in human esophageal squamous
cell carcinoma using RT-PCR. Med Mol Morphol. 42:102–109. 2009.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Feber A, Xi L, Luketich JD, et al:
MicroRNA expression profiles of esophageal cancer. J Thorac
Cardiovasc Surg. 135:255–260. 2008. View Article : Google Scholar
|
20
|
Guo J, Miao Y, Xiao B, et al: Differential
expression of microRNA species in human gastric cancer versus
non-tumorous tissues. J Gastroenterol Hepatol. 24:652–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Fridman E, Dotan Z, Barshack I, et al:
Accurate molecular classification of renal tumors using microRNA
expression. J Mol Diagn. 12:687–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hiroki E, Akahira J, Suzuki F, et al:
Changes in microRNA expression levels correlate with
clinicopathological features and prognoses in endometrial serous
adenocarcinomas. Cancer Sci. 101:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Miles GD, Seiler M, Rodriguez L, Rajagopal
G and Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian
cancer. BMC Res Notes. 5:1642012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Au SL, Wong CC, Lee JM, et al: Enhancer of
zeste homolog 2 epigenetically silences multiple tumor suppressor
microRNAs to promote liver cancer metastasis. Hepatology.
56:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yu JJ, Wang Y, Dong RF, Huang XY, Ding SN
and Qiu HF: Circulating microRNA-218 was reduced in cervical cancer
and correlated with tumor invasion. J Cancer Res Clin Oncol.
138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Tatarano S, Chiyomaru T, Kawakami K, et
al: miR-218 on the genomic loss region of chromosome 4p15.31
functions as a tumor suppressor in bladder cancer. Int J Oncol.
39:13–21. 2011.PubMed/NCBI
|
28
|
Gao CP, Zhang ZY, Liu WZ, Xiao SD, Gu WQ
and Lu H: Reduced microRNA-218 expression is associated with high
nuclear factor kappa B activation in gastric cancer. Cancer.
116:41–49. 2010.PubMed/NCBI
|
29
|
Huang XH, Chen JS, Wang Q, et al:
miR-338-3p suppresses invasion of liver cancer cell by targeting
smoothened. J Pathol. 225:463–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yu J, Li A, Hong SM, Hruban RH and Goggins
M: MicroRNA alterations of pancreatic intraepithelial neoplasias.
Clin Cancer Res. 18:981–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Foss KM, Sima C, Ugolini D, Neri M, Allen
KE and Weiss GJ: miR-1254 and miR-574-5p: serum-based microRNA
biomarkers for early-stage non-small cell lung cancer. J Thorac
Oncol. 6:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yao Y, Suo AL, Li ZF, et al: MicroRNA
profiling of human gastric cancer. Mol Med Rep. 2:963–970.
2009.PubMed/NCBI
|
33
|
Ohdaira H, Nakagawa H and Yoshida K:
Profiling of molecular pathways regulated by microRNA 601. Comput
Biol Chem. 33:429–433. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lowery AJ, Miller N, Dwyer RM and Kerin
MJ: Dysregulated miR-183 inhibits migration in breast cancer cells.
BMC Cancer. 10:5022010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Schaefer A, Jung M, Mollenkopf HJ, et al:
Diagnostic and prognostic implications of microRNA profiling in
prostate carcinoma. Int J Cancer. 126:1166–1176. 2010.PubMed/NCBI
|
36
|
Li J, Fu H, Xu C, et al: miR-183 inhibits
TGF-beta1-induced apoptosis by downregulation of PDCD4 expression
in human hepatocellular carcinoma cells. BMC Cancer. 10:3542010.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
38
|
Sarver AL, Li LH and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
39
|
Li GR, Luna C, Qiu JM, Epstein DL and
Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by
microRNA 183. J Biol Chem. 285:5461–5471. 2010. View Article : Google Scholar : PubMed/NCBI
|
40
|
Kanasaki K, Kanda Y, Palmsten K, et al:
Integrin beta1-mediated matrix assembly and signaling are critical
for the normal development and function of the kidney glomerulus.
Dev Biol. 313:584–593. 2008. View Article : Google Scholar : PubMed/NCBI
|
41
|
Wederell ED and de Iongh RU: Extracellular
matrix and integrin signaling in lens development and cataract.
Semin Cell Dev Biol. 17:759–776. 2006. View Article : Google Scholar : PubMed/NCBI
|
42
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.PubMed/NCBI
|
43
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
45
|
Greither T, Grochola LF, Udelnow A,
Lautenschlager C, Wurl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
46
|
Jiang SA, Zhang HW, Lu MH, et al:
MicroRNA-155 functions as an OncomiR in breast cancer by targeting
the suppressor of cytokine signaling 1 gene. Cancer Res.
70:3119–3127. 2010. View Article : Google Scholar : PubMed/NCBI
|
47
|
Wang G, Chan ES, Kwan BC, et al:
Expression of microRNAs in the urine of patients with bladder
cancer. Clin Genitourin Cancer. 10:106–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
48
|
Chiang YP, Song YX, Wang ZN, et al:
microRNA-192,-194 and-215 are frequently downregulated in
colorectal cancer. Exp Ther Med. 3:560–566. 2012.PubMed/NCBI
|
49
|
Rossing M, Borup R, Henao R, et al:
Down-regulation of microRNAs controlling tumourigenic factors in
follicular thyroid carcinoma. J Mol Endocrinol. 48:11–23. 2012.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Wang LL, Zhang ZF, Li Q, et al: Ethanol
exposure induces differential microRNA and target gene expression
and teratogenic effects which can be suppressed by folic acid
supplementation. Hum Reprod. 24:562–579. 2009. View Article : Google Scholar : PubMed/NCBI
|
51
|
Soares AR, Pereira PM, Ferreira V, et al:
Ethanol exposure induces upregulation of specific microRNAs in
zebrafish embryos. Toxicol Sci. 127:18–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
52
|
Miranda RC, Pietrzykowski AZ, Tang Y, et
al: MicroRNAs: master regulators of ethanol abuse and toxicity?
Alcohol Clin Exp Res. 34:575–587. 2010. View Article : Google Scholar : PubMed/NCBI
|